Cynthia Duprey, NP
Nurse Practitioner · Holly Springs, GANPI 1780026013
Payments from drug & device makers
Across 93 payments — averaging $33.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$454
- AstraZeneca$304
- Pfizer$290
- Daiichi Sankyo Inc.$229
- Karyopharm Therapeutics Inc.$165
- Seagen Inc.$143
- plus $2K from 29 others
What the payments were for
- Consulting fees$1003%
- Food & beverage$2,81991%
- Education$1906%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $454 |
| AstraZeneca | 5 | $304 |
| Pfizer | 10 | $290 |
| Daiichi Sankyo Inc. | 11 | $229 |
| Karyopharm Therapeutics Inc. | 4 | $165 |
| Seagen Inc. | 3 | $143 |
| Novartis | 6 | $129 |
| GSK | 3 | $128 |
| Beigene USA, Inc. | 1 | $125 |
| AbbVie | 5 | $118 |
| Genentech USA, Inc. | 1 | $107 |
| Impel Pharmaceuticals Inc. | 1 | $103 |
| Amgen | 4 | $81 |
| Jazz Pharmaceuticals Inc. | 4 | $80 |
| Merck | 3 | $79 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $73 |
| Eisai Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $52 |
| Pharmaessentia USA Corporation | 1 | $32 |
| Bayer | 1 | $25 |
| Dendreon Pharmaceuticals LLC | 1 | $23 |
| Bristol Myers Squibb | 1 | $23 |
| Sobi, Inc | 1 | $22 |
| Syndax Pharmaceuticals, Inc. | 1 | $21 |
| Coherus Oncology, Inc. | 1 | $21 |
| ADC Therapeutics America, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Beone Medicines USA, Inc. | 1 | $20 |
| Mirati Therapeutics, Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Exelixis Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,110 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 12 | $178 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Holly Springs
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.